Search

Search Results
Results 2811 - 2820 of 3175 for wound care
  • Vancomycin Alphapharm
    Drug - 19 Sep 2024
    Consumer Medicine Information (CMI) about Vancomycin Alphapharm intended for persons living in Australia.
  • Mounjaro KwikPen
    Drug - 12 Sep 2024
    Consumer Medicine Information (CMI) about Mounjaro KwikPen intended for persons living in Australia.
  • Rimycin
    Drug - 12 Sep 2024
    Consumer Medicine Information (CMI) about Rimycin intended for persons living in Australia.
  • Azithromycin Viatris Tablets
    Drug - 12 Sep 2024
    Consumer Medicine Information (CMI) about Azithromycin Viatris Tablets (Azithromycin dihydrate) intended for persons living in Australia.
  • Amlodipine/Valsartan/HCT Novartis
    Drug - 10 Sep 2024
    Consumer Medicine Information (CMI) about Amlodipine/Valsartan/HCT Novartis intended for persons living in Australia.
  • Exforge HCT
    Drug - 10 Sep 2024
    Consumer Medicine Information (CMI) about Exforge HCT intended for persons living in Australia.
  • Bijuva 1/100
    Drug - 6 Sep 2024
    Consumer Medicine Information (CMI) about Bijuva 1/100 intended for persons living in Australia.
  • Tixol (New Formulation)
    Drug - 6 Sep 2024
    Consumer Medicine Information (CMI) about Tixol (New Formulation) intended for persons living in Australia.
  • Acarbose Viatris
    Drug - 6 Sep 2024
    Consumer Medicine Information (CMI) about Acarbose Viatris intended for persons living in Australia.
  • Seasonal patterns in Valley fever cases reveal climate-driven risks
    News - 4 Sep 2024
    Valley fever is an emerging fungal disease in the western United States that most often causes flu-like symptoms, but can also cause dangerous or even deadly complications. By analyzing data on...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback